Analyst firms · Morgan Stanley · ABBV
Morgan Stanley ABBV price target and rating history
AbbVie Inc. (ABBV) · Health Care
Morgan Stanley rates AbbVie Inc. (ABBV) Overweight with a $192 price target, as of its latest action on Apr 6, 2022. It has published 3 rating actions on ABBV since November 2021, including 0 upgrades and 0 downgrades. Across 7 firms with a ABBV price target in the last 12 months, the median target is $262.
- Current rating
- Overweight
- Price target
- $192
- Median target, all firms
- $262
- Actions on ABBV
- 3
Morgan Stanley price target on ABBV
Every Morgan Stanley rating on ABBV
- Apr 6, 2022
- Jan 24, 2022
- Nov 1, 2021
How other firms rate ABBV
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wolfe Research | Outperform | $300 | Aug 13, 2026 |
| Erste Group | Buy | Aug 5, 2026 | |
| BofA Securities | Buy | $234 | Apr 30, 2026 |
| Canaccord Genuity | Buy | $262 | Apr 21, 2026 |
| RBC Capital Markets | Outperform | $260 | Feb 25, 2026 |
| Barclays | Overweight | $275 | Feb 20, 2026 |
| UBS | Neutral | $240 | Jan 7, 2026 |
| HSBC | Buy | $265 | Dec 10, 2025 |
Questions about Morgan Stanley and ABBV
- What is Morgan Stanley's price target for ABBV?
- Morgan Stanley's latest stated price target for AbbVie Inc. (ABBV) is $192, from its action on Apr 6, 2022.
- What is Morgan Stanley's rating on ABBV?
- Morgan Stanley rates ABBV Overweight, a bullish rating, as of Apr 6, 2022.
- When did Morgan Stanley last change its view on ABBV?
- On Apr 6, 2022, Morgan Stanley resumes coverage at Overweight, price target $192.
- How does Morgan Stanley's ABBV target compare with other analysts?
- Across 7 firms with a ABBV price target in the last 12 months, the median target is $262.
More ABBV rating histories
All Morgan Stanley ratingsABBV news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.